Listen "Repurposing loperamide to target glioma, metabolic reprogramming, liquid biopsies. "
Episode Synopsis
In this episode, recorded just before the New Year, I discuss recent news in brain cancer research. This includes:How the drug loperamide (brand name Imodium), induces cell death in glioblastoma cell lines and if this could have promise for real, human applications. Metabolic reprogramming via inhibition of a key cancer metabolite- D-2-Hydroxyglutarate (D-2-HG).Developments of liquid biopsies for glioma.
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.